Health Diplomacy with Chinese Characteristics

This article examines China’s health diplomacy as an increasingly important component of its foreign policy strategy and global political positioning. The COVID-19 pandemic, by securitizing public health and exposing the geopolitical dimension of medical assistance, substantially increased the relevance of health diplomacy as a sphere in which states pursue national interests, cultivate international legitimacy, and compete for influence. The People’s Republic of China represents one of the most significant cases in this regard, since Beijing has described its pandemic-era assistance as the largest medical aid operation in the country’s history.

The article traces the evolution of China’s approach to health diplomacy from the early use of medical teams in the developing world to the contemporary Health Silk Road, one of the specialized dimensions of the Belt and Road Initiative. The study argues that China’s health diplomacy has entered a new stage characterized by pragmatism, the combined use of soft and hard power, an emphasis on South–South cooperation and appeals to moral responsibility. These features are conceptualized as health diplomacy with Chinese characteristics.

The theoretical framework draws on public diplomacy, soft power, geopolitical interpretations of vaccine diplomacy, and Chinese foreign policy concepts, including Mao Zedong’s theory of the three worlds, Hu Jintao’s idea of China as a responsible global power, Xi Jinping’s concept of a community with a shared future for mankind, and Yan Xuetong’s moral realism. The empirical basis includes Chinese white papers, documents related to the Health Silk Road, official statements, WHO materials, vaccine and health expenditure trackers, statistics, expert reports, media publications, and academic literature.

The article shows that China used the COVID-19 pandemic both to present itself as a responsible global power capable of contributing to the management of a worldwide crisis and to gain economic and political benefits. However, Beijing was unable to fully transform these opportunities into sustainable international leadership. Its health diplomacy faces external constraints, including geopolitical rivalry with the United States, distrust toward Chinese intentions, and criticism of vaccine and mask diplomacy, as well as internal limitations related to China’s own healthcare system, transparency deficits, and the absence of a comprehensive global health strategy.

The article concludes that China is not yet ready to achieve and maintain leadership in global health diplomacy. Nevertheless, the institutionalization of the Health Silk Road, regional coalition-building, and the integration of health diplomacy into China’s broader foreign policy strategy suggest that health diplomacy will remain an important instrument through which Beijing seeks to strengthen its international position and influence global health governance.

1. Bialasiewicz L. 2021. Vaccine Geopolitics, “Big” and “Small”, and Europe’s Challenge. Green European Journal. 29 January. URL: https://www.greeneuropeanjournal.eu/vaccine-geopoliticsbig-and-small-and-europes-challenge/ (accessed 07.12.2025)

2. Bourne P. 1978. A Partnership for International Health Care. Public Health Reports. 93(2). P. 114–123.

3. Chan G. 2024. China’s Health Silk Road. Vaccine Diplomacy and Health Governance. Cheltenham: Edward Elgar Publishing. 166 p.

4. Chan L.-H., Chen L., Xu J. 2010. China’s Engagement with Global Health Diplomacy: Was

5. SARS a Watershed? PLoS Medicine. 7(4). P. 1–6. DOI: 10.1371/journal.pmed.1000266

6. Chen I.T.Y. 2022. The Crisis of COVID-19 and the Political Economy of China’s Vaccine Diplomacy. Foreign Policy Analysis. 18(3). DOI: 10.1093/fpa/orac014

7. Chow-Bing N. 2020. COVID-19, Belt and Road Initiative and the Health Silk Road: Implications for Southeast Asia. Jakarta: Friedrich-Ebert-Stiftung. 22 p.

8. Cohen J. 2020. China’s Vaccine Gambit. Science. 370(6522). P. 1263–1267. DOI: 10.1126/science.370.6522.1263

9. Colley T., Van Noort C. 2022. China’s COVID-19 Strategic Narratives in 2020 and How States Responded to Them. Strategic Narratives, Ontological Security and Global Policy: Responses to China’s Belt and Road Initiative. Cham: Palgrave Macmillan. P. 211–264.

10. Fauci A.S. 2007. The Expanding Global Health Agenda: A Welcome Development. Nature Medicine. 13(10). P. 1169–1171. DOI: 10.1038/nm1646

11. Fazal T.M. 2020. Health Diplomacy in Pandemical Times. International Organization. 74(S1). P. 78–97. DOI: 10.1017/S0020818320000326

12. Hosseini Divkolaye N.S., Radfar M.H., Seighali F., Buckley Jr F.M. 2016. When Health Diplomacy Serves Foreign Policy: Use of Soft Power to Quell Conflict and Crises. Disaster Medicine and Public Health Preparedness. 10(5). P. 724–727. DOI: 10.1017/dmp.2016.31

13. Huang Y. 2010. Pursuing Health as Foreign Policy: The Case of China. Indiana Journal of

14. Global Legal Studies. 17(1). P. 105–146. DOI: 10.2979/gls.2010.17.1.105

15. Huang Y. 2012. China and Global Health Governance. SSRN Electronic Journal. DOI: 10.2139/ ssrn.2169847

16. Huang Y. 2013. Governing Health in Contemporary China. London: Routledge. 192 p. DOI: 10.4324/9780203078549

17. Hyndman J. 2021. Vaccine Geopolitics During COVID-19: How Pandemics Thicken Borders, Exacerbate Violence, and Deepen Existing Fault Lines. COVID-19 and Similar Futures. Pandemic Geographies. Cham: Springer. P. 193–198. DOI: 10.1007/978-3-030-70179-6_25

18. Jakóbowski J. 2018. Chinese-Led Regional Multilateralism in Central and Eastern Europe, Africa and Latin America: 16+1, FOCAC, and CCF. Journal of Contemporary China. 27(113). P. 659–673. DOI: 10.1080/10670564.2018.1458055

19. Kickbusch I. 2011. Global Health Diplomacy: How Foreign Policy Can Influence Health. British Medical Journal. №342. DOI: 10.1136/bmj.d3154.

20. Killeen O.J., Davis A., Tucker J.D., Meier B.M. 2018. Chinese Global Health Diplomacy in Africa: Opportunities and Challenges. Global Health Governance. 12(2). P. 4–29.

21. Kobierecka A., Kobierecki M.M. 2021. Coronavirus Diplomacy: Chinese Medical Assistance and Its Diplomatic Implications. International Politics. 58(1). P. 937–954. DOI: 10.1057/s41311-020-00273-1

22. Lee K., Smith R. 2011. What is ‘Global Health Diplomacy’? A Conceptual Review. Global Health Governance. 5(1). P. 1–12.

23. Li A. 2007. China and Africa: Policy and Challenges. China Security. 3(3). P. 69–93.

24. Liu P., Yan Guo Y., Qian X. et al. 2014. China’s Distinctive Engagement in Global Health.

25. Lancet. 384 (9945). P. 793–804. DOI: 10.1016/S0140-6736(14)60725-X

26. Liu Z., Wang Z., Xu M. et al. 2023. The Priority Areas and Possible Pathways for Health Cooperation in BRICS Countries. Global Health Research and Policy. 8(1). DOI: 10.1186/s41256-02300318-x

27. Mol R., Singh B., Chattu V.K. et al. 2021. India’s Health Diplomacy as a Soft Power Tool towards Africa: Humanitarian and Geopolitical Analysis. Journal of Asian and African Studies. 57(6). DOI: 10.1177/00219096211039539

28. Nolte D. 2023. China’s Mask and Vaccine Diplomacy in Latin America: A Success Story? International Politics. DOI: 10.1057/s41311-023-00525-w

29. Qiao J., Zhan S., Ren M. et al. 2025. A New Phase of China-ASEAN Health Cooperation: The China-ASEAN Beijing Declaration on Cooperation in Innovation of Health Products and Technologies. Global Health Research and Policy. 10. DOI: 10.1186/s41256-024-00401-x

30. Rodrigues Santiago A., Tritto T. 2025. China-Africa Community with Shared Benefits: Health Cooperation and Its Wider Political and Economic Implications. The Palgrave Handbook on ChinaEurope-Africa Relations. Singapore: Palgrave Macmillan. P. 407–421. DOI: 10.1007/978-981-97-5640-7_19

31. Rosas González M., Magaña Huerta P., Haro Barón T. 2023. La ruta sanitaria de la seda y el poder suave de la República Popular China ante el SARS-CoV-2. Foro Internacional. №1. P. 85–132. DOI: 10.24201/fi.v63i1.2937

32. Rudolf M. 2021. China’s Health Diplomacy During COVID-19: The Belt and Road Initiative (BRI) in Action. SWP Comment. №9. URL: https://www.swp-berlin.org/publications/products/ comments/2021C09_ChinaHealthDiplomacy.pdf (accessed 12.04.2026)

33. Rudolf M. 2022. China’s Global Health Diplomacy. Revisiting Beijing’s preand post-COVID-19 Outreach Efforts. Bonn: Friedrich-Ebert-Stiftung. 35 p.

34. Suzuki M., Yang Sh. 2023. Political Economy of Vaccine Diplomacy: Explaining Varying Strategies of China, India, and Russia’s COVID-19 Vaccine Diplomacy. Review of International Political Economy. 30(3). P. 865–890. DOI: 10.1080/09692290.2022.2074514

35. Tang B., Hu H. 2023. Diplomatic Partnership Building and Transformation of ChinaMiddle East Health Cooperation. Chinese Journal of International Review. 5(2). DOI: 10.1142/S2630531323500105

36. Tang K., Li Zh., Li W., Chen L. 2017. China’s Silk Road and Global Health. Lancet. 390(10112). P. 2595–2601. DOI: 10.1016/s0140-6736(17)32898-2

37. Thompson D. 2005. China’s Soft Power in Africa: From the ‘Beijing Consensus’ to Health Diplomacy. China Brief: A Journal of Information and Analysis. 5(21). P. 1–4.

38. Van Dijk R., Lo C. 2023. The Effect of Chinese Vaccine Diplomacy During COVID-19 in the Philippines and Vietnam: A Multiple Case Study from a Soft Power Perspective. Humanities and Social Sciences Communications. №10. DOI: 10.1057/s41599-023-02073-3

39. Vankovska B. 2021. Geopolitics of Vaccines: War by Other Means? Security Dialogues. 12(2). P. 41–56. DOI: 10.47054/SD21122041v

40. Warmerdam W., Haan A. de. 2019. South–South Cooperation with Chinese Characteristics. Innovating South–South Cooperation: Policies, Challenges and Prospects / Ed. by H.G. Besada, M.E. Tok, L.M. Polonenko. Ottawa: University of Ottawa Press. P. 141–172.

41. Yan X. 2016. Political Leadership and Power Redistribution. The Chinese Journal of International Politics. 9(1). P. 1–26. DOI: 10.1093/cjip/pow002

42. Yan X. 2019. Leadership and the Rise of Great Powers. Princeton: Princeton University Press. 280 p.

43. Youde J. 2010. China’s Health Diplomacy in Africa. China: An International Journal. 8(1). P. 151–163. DOI: 10.1142/S0219747210000099

44. Yuan Sh. 2023. The Health Silk Road: A Double-Edged Sword? Assessing the Implications of China’s Health Diplomacy under Covid-19. World. 4(2). P. 333–346. DOI: 10.3390/world4020021

45. Zeng W., Ding M., Liu H. 2023. China’s Health Silk Road Construction During the COVID-19 Pandemic. Global Public Health. 18(1). DOI: 10.1080/17441692.2023.2185799

46. Zhang X., Zhao C., Shao M. et al. 2022. The Roadmap of Bioeconomy in China. Engineering Biology. 6(4). P. 71–81. DOI: 10.1049/enb2.12026

47. Zhao L., Wang B. 2022. China’s Public Health Diplomacy in the Post Covid-19 Era. Journal of Chinese Economic and Business Studies. 20(3). P. 235–244. DOI: 10.1080/14765284.2022.2056380

48. Arsentyeva I.I. 2022. Transformatsiya meditsinskoi i vaktsinnoi diplomatii v ehpokhu COVID-19 [Transformations of Medical and Vaccine Diplomacies in the COVID-19 Era]. MGIMO Review of International Relations. 15(5). P. 182–207. DOI: 10.24833/2071-8160-2022-5-86-182-207. (In Russian)

49. Arsentyeva I.I. 2025. Kitaiskii Shelkovyi put' zdorov'ya [China’s Health Silk Road]. World Economy and International Relations. 69(1). P. 30–38. DOI: 10.20542/0131-2227-2025-69-1-30-38. (In Russian)

50. Lebedeva M.M. 2020. Konceptual'nye perevoploshhenija publichnoj diplomatii [Conceptual

51. Transformations of Public Diplomacy]. MGIMO Review of International Relations. 13(5). P. 293–306. DOI: 10.24833/2071-8160-2020-5-74-293-306. (In Russian)

52. Leksyutina Ya.V. 2018. Kitai kak otvetstvennaya velikaya derzhava: ozhidaniya Zapada i politika Pekina [China, Great Power Responsibility, and Global Leadership]. International Trends. 16(2). P. 293–306. DOI: 10.24833/2071-8160-2020-5-74-293-306. (In Russian)

53. Portyakov V.Ya. 2013. Stanovlenie Kitaja kak otvetstvennoj global'noj derzhavy [China’s Emergence as a Responsible Global Power]. Moscow: IFES RAS. 238 p. (In Russian)

54. Rogozhina N.G. 2021. Masochnaja diplomatija Kitaja v stranah Jugo-Vostochnoj Azii [The Mask Diplomacy of China in Southeast Asia]. South East Asia: Actual problems of Development. 1(1). P. 73–81. DOI: 10.31696/2072-8271-2021-1-1-50-073-081. (In Russian)

55. Zhuravleva E.V. 2021. Medicinskaya diplomatiya kak instrument politiki «myagkoj sily» KNR [Medical Diplomacy as a Soft Power Instrument of the PRC]. Kommunisticheskij Kitaj. Celi i zadachi k stoletnemu yubileyu KPK. Moscow: IFES RAS. P. 224–239. (In Russian)

56. Кharkevich M.V., Zinovieva E.S. 2022. «Vaktsinnyi natsionalizm» v kontekste konkurentsii velikikh derzhav: analiz s pozitsii teorii sek'yuritizatsii [“Vaccine Nationalism” as a Great Power Competition: Analysis from the Standpoint of the Securitization Theory]. Science Journal of VolSU. History. Area Studies. International Relations. 27(2). P. 137–150. DOI: 10.15688/jvolsu4.2022.2.12. (In Russian)